Akums reports Q1 FY26 PAT at Rs. 65 Cr
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Athena is also exploring the use of this technology for expanded carrier screening
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Subscribe To Our Newsletter & Stay Updated